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Abstract
T cell precursors from murine fetal liver enter the fetal thymus where they proliferate,
differentiate, and mature. These processes are accompanied by changes in the pattern of
transcription factors known to control the expression of specific genes. We have monitored the
expression of five different transcription factors during mouse fetal thymus ontogeny: nuclear
factor (NF)-xB, cAMP-response-element binding protein (CREB), NF-IL-2A, msNF-AT1, and hNF-
AT1. NF-xB binding activity was not detected in extracts from fetal liver but was present in the
thymus at day 14 of embryogenesis. Thereafter, NF-xB expression was biphaslc, being maximal
at 14 -16 days gestation and in newborn mice, and decreased during the intermediate
gestational stages and in the adult. An inverse correlation was observed between NF-xB binding
activity in the nuclei and levels of its Inactive precursor in the cytoplasm of all samples analyzed.
In contrast, CREB activity was uniform throughout thymus development. Similarly, NF-IL-2A
activity was detected In fetal liver and thymic extracts from different gestational stages, In
approximately equivalent amounts. However, band shift experiments revealed three distinct
NF-IL-2A - DNA complexes, whose relative abundance is altered during thymic ontogeny.
Likewise, NF-AT1 transcription factor appears to be heterogeneous and includes representatives
which are differentially (msNF-AT1) or stably (hNF-AT1) expressed during thymic development.
These results are discussed in the context of present knowledge about T cell development within
the thymus.
Introduction
Complex cell -cell interactions, hormones, growth factors, and
other extracellular inducers are known to activate specific patterns
of genes in target cells during development or in response to
the environment. Regulation of gene expression occurs at several
different levels, but the activation of /rans-acting protein factors
of transcription (which mediate differential gene transcription by
binding to their cognate c/s-acting elements in gene promoters
and enhancers) is perhaps the most fundamental (1,2).
Regulatory regions of eukaryotic genes contain specific
combinatorial patterns of c/s-acting elements, which are frequently
similar and bind ubiquitous transcription factors. However, some
transcription factors have a more restricted tissue or cell
distribution and mediate tissue-specific gene expression. The best
examples of such are the transactivator MyoD, a product of the
muster regulatory gene for myogenesis myoD, the transcription
factor GATA-1, which is restricted to hematopoietic cells, and the
transcription factor HNF1/LFB1 that is enriched in the liver (3 - 5)
Until now, relatively little information has been available
regarding T cell specific or T cell associated transcription factors.
Possible candidates include TCF1a/LEF1, which is essential for
T cell receptor a chain (TCR-a) and CD4 gene transcription (6,7),
and GATA-3, which binds to several TCR regulatory elements
(8,9). Much more is known about ubiquitous transcription factors
such as nuclear factor (NF)-xB and cAMP-responsive-element
binding protein (CREB). NF-xB activity has been found in nuclear
fractions of many different cell types, but particularly within nuclei
of cells of the immune system. Most target genes for this factor
can be divided into three groups: (i) genes encoding
immunomodulatory cytokines such as IL-2, IL-6, tumor necrosis
factor-a (TNF-a), and granulocyte macrophage colony stimulating
factor (GM-CSF), (ii) genes encoding immunoregulatory surface
receptors such as IL-2 receptor a chain (IL-2Ror), the MHC class
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I proteins (MHC I) and the invariant chain of MHC class II; and
(iii) acute phase proteins including serum amyloid A precursor
(for reviews, see refs 10 and 11).
CREB is responsible for transcriptional activation of different
cAMP-inducible genes (for review, see ref. 12). CREB, or related
proteins, activate the murine TCR-/3 chain transcription, binding
to the c/s-element CRE found in the Vs promoter and TCR-/3
enhancer regions (13,14). In addition, the transactivator CREB
is known to bind to both human and mouse 3' TCR-a enhancers
(15) and a CRE motif has been found in the 3' enhancer of the
human CD2 gene (16).
There are at least two other important regulators of transcrip-
tion in T lymphocytes, i.e. factors NF-AT1 and NF-IL2A. These
factors recognize cognate elements which were originally describ-
ed within the IL-2 gene regulatory region (17-20). Recently, it
has been shown that the NF-AT1 binding site has a complex
structure and also contains an Ets cognate sequence (21). In ad-
dition, Ets binding sites have been found in the regulatory regions
of many genes having T cell specific expression, i.e. CD2, CD35,
CD3e, TCR-a, TCR-/3, and TCR-6 (21).
Most studies dealing with transcription factors and the genetic
regulatory events in T lymphocytes have been restricted to ex-
amining events in mature T cell activation (22). Relatively little
is known about transcriptional control in developing thymocytes.
However, because complex cell-cell interactions between
stroma and thymocytes are known to control development within
the thymus, it seems likely that transcription factors mediate at
least some of these events. T cell precursors derived from fetal
liver enter the fetal thymus anlage via the blood stream and then
undergo a complex series of differentiation and maturation
events. During this process, rapidly dividing immature
CD4"CD8~ cells differentiate through an intermediate stage
(CD4+CD8+) expressing both CD4 and CD8 before finally
giving rise to cells expressing either CD4+ or CD8+. These
latter 'mature' thymocytes express clonally elaborated TCR
molecules and are immunologically competent (for review, see
ref. 23). During mouse fetal thymus development, CD4+CD8+
(double positive) and cells expressing either CD4 or CD8 (single
positive) appear at days 16 and 18-19 respectively (24). In this
study, we investigated the changes in transcription factor
expression that accompany these complex intrathymic events.
In the first instance, we examined nuclear and cytoplasmic
extracts prepared from fetal thymocytes starting at day 14 of
embryonic development for a variety of transcription factors. The
results obtained showed that transcription factor levels are tightly
regulated during thymic development.
Methods
Oligonucleotides
Synthetic oligonucleotides were end-labeled with [-^PJATP
using T4 polynucleotide kinase (25). Sequences of doubJe-
stranded oligonucleotides used in this study are shown in Table 1.
Thymocyte preparation
Cell suspensions were prepared from the thymuses of fetal,
newborn, or 4 week old adult (C57BI/6 x DBA/2)F, mice. Fetal
mice were obtained from timed matings of DBA/2 female and
C57BI/6 male mice, and the date of finding the vaginal plug was
taken as day 0 of development. Fetal thymuses were removed
using a dissecting microscope and cell suspensions prepared
by passing thymus lobes through hypodermic needles of
decreasing size as previously described (26).
Nuclear and cytosol extract preparation and electrophoretic
mobility-shift assay (EMSA)
Nuclear and cytoplasmic extracts were prepared from fresh
thymuses using a modification of the techique described by
Dignam et al. (27,28). Buffers contained the protease inhibitors
phenytmethylsulfonyl fluoride (PMSF) (0.5 mM), and 5 /ig/ml each
of leupeptm, aprotinin, pepstatin, chymostatin, and antipain
Proteins were quantified by the method of Bradford (29). Binding
reactions were carried out by incubating the end-labeled DNA
(20 000 c.p.m.) with 1 - 2 ^g of nuclear or 5 -10 ^g cytoplasmic
proteins and 2 HQ of poly(dl -dC) in a buffer containing 10 mM
HEPES (/V-2-hydroxyethy1piperazine-/V'-2-ethanesulfonic acid),
pH 7.9, 60 mM KCI, 4% Ficoll, 1 mM EDTA (30). After 30 min
at room temperature, the reaction mixtures were loaded onto a
4% polyacrylamide gel in 0.25 x TBE buffer (TBE: 89 mM Tris,
89 mM boric acid, 2 mM EDTA) and electrophoresed at 10 V/cm
for 1.5 h at room temperature. For competition experiments, a
100- to 400-fold molar excess of unlabeled oligonucleotide was
added to the reaction mixture prior to the addition of labeled DNA.
The treatment of cytosolic fractions with 0.6% deoxycholate
(DOC) in the presence of 1.2% NP-40 was performed during the
binding reaction as described by Baeuerle and Baltimore (31).
Photo-affinity labeling of sequence-specific proteins (UV
crosslinking)
DNA-protein UV crosslinking was performed using a
modification of the method reported by Wu et al. (32). The first
stage of the binding reaction was the same as that for EMSA
except for an increased concentration (up to 60 000 c p.m.) of
the labeled DNA probes. After 30 min at room temperature, the
reaction mixtures (in open tubes) were placed on ice 5 cm from
an inverted 254 nm UV transilluminator and irradiated for 20 min.
Then, an equal volume of 2% sodium dodecylsulfate (SDS), 10%
2-mercaptoethanol, 0.1 M Tris-HCI, pH 7.0, 20%glycerol, and
Bromphenol blue dye was added. The samples were boiled for
2 min and subjected to electrophoresis in 0.1% SDS-10%
polyacrylamide gels followed by autoradiography.
Results
NF-xB binding activity in fetal and adult thymus
To probe for NF-xB binding activity in nuclear extracts of
thymocytes, EMSA was used with three different labeled probes:
a xB oligonucleotide from the human immunodeficiency virus
(HIV) type 1 enhancer (*B), a mutated variant of this oligo-
nucleotide with three point mutations in the binding site (mxB),
and a palindromic variant of the xB element from the MHC class
I gene promoter region (MHC-xB) (Table 1). Incubation of the
radiolabeled xB oligonucleotide with nuclear extracts of
thymocytes from newborn and adult mice revealed two discrete,
electrophoretically retarded DNA - protein complexes (b1 and
b2) (Fig. 1). These two bands were observed more clearly after
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"Known binding sites of transcription factors are underlined.
bMutated nucleotides are shown in bold.
cEts-binding site is shown in italic
dNon-canonical Oct-bindmg site is shown in italic.
shorter exposure of autoradiograms (Fig. 2, panel B). The
formation of these complexes was inhibited by preincubation with
a 200-fold molar excess of unlabeled xB oligonucleotide but was
not inhibited by excess unlabeled mxB oligonucleotide (Fig. 1,
lanes 2, 5 and 3, 6 respectively). Incubation of the radidabeled
m*B oligonucleotide with nuclear extracts from newborn or adult
thymocytes did not produce any significant DNA- protein
complexes (Fig. 1, lanes 7 and 8). Hence, NF-xB binding activity
was specific in nuclear extracts from mouse thymocytes.
Using labeled MHC-xB oligonucleotides, EMSA produced the
same retarded DNA - protein complexes as with the xB probe
(Fig. 1, lane 9, bands b1 and b2). However, two differences were
noted between EMSA experiments with the xB and MHC-xB
oligonucleotides. Firstly, a shorter exposure of EMSA showed
that with the MHC-xB oligonucleotide (Fig. 2C, lanes 10-12),
the two bands b1 and b2 were of approximately equal intensity
for newborn thymus extracts, whereas with the xB oligonucleotide
(Fig. 2B) band b1 was consistently more intense than band b2.
Secondly, in competition experiments, a 200-fold excess of
unlabeled xB-oligonucleotide failed to completely inhibit the
appearance of band b2 (Fig. 1, lane 11). Taken together, these
results would seem to agree with the recent reports of Ghosh
et al. (33) and Urban and Baeuerle (34) who suggested that the
upper band b1 may result from the interaction of the
heterodimeric p65-p50 form of NF-xB with the xB
oligonucleotide, while the lower band b2 was the result of the
interaction of the homodimeric p5O - p50 form of NF-xB with the
same probe. These results suggest that the palindromic MHC-
xB oligonucleotide may bind equally well to both isoforms of
NF-xB, whereas the non-palindromic xB oligonucleotide has a
higher affinity for the p65-p50 NF-xB complex.
We used UV crossfinking of the xB probe to NF-xB-like proteins
from newborn thymocyte extracts to determine the subunit
composition of these proteins (Fig. 1B). Taking into account the
molecular weight of the oligonucleotide probe, SDS-PAGE
showed that newborn thymus NF-xB-like protein had the
canonical subunit composition for NF-xB factor (35) with apparent
molecular weights of 65 and 50 kDa. Labeling of these proteins
was inhibited by a excess of xB oligonucleotide but not of rrtxB
oligonucleotide (Fig. 1B), again showing the specificity of the
interaction being measured.
These experiments established the specificity of NF-xB
detection. NF-xB binding activity during mouse thymus ontogeny
was then determined. Results of these experiments are shown
in Fig. 2. The first time point studied was day 14 of embryonic
development. For these experiments, nuclear extracts of
thymocytes were prepared from a pool of 40 -50 mice,
equivalent to 1.5-2 x 106 cells, and in all experiments equal
amounts of protein were used in each reaction. These studies
showed that NF-xB binding activity was high on days 14-16
of development with a significant decrease during days 17 and
18. After birth, NF-xB levels increased slightly before reaching
the adult thymus level (Fig. 2). Importantly, the intensity of the
upper b1 band, which corresponds to the p65-p50 complex
of NF-xB, was greater early in fetal thymus development (Fig.
2BandC, lane 1 -3) . In the newborn thymus (lanes 10-12) the
intensity of bands b1 and b2 were approximately equal.
It is well known that in many different tissues there is a
cytoplasmic precursor pool of NF-xB factor. The heterodimeric
complex of p65 - p50 NF-xB interacts with the inhibitory protein
IxB which keeps NF-xB in the cytoplasm in an inactive form
(36,37). Treating cytoplasmic extracts with DOC dissociates NF-
xB from IxB and thereby reveals the presence of an inactive
cytoplasmic pool of NF-xB. Mouse fetal thymocyte cytoplasmic
extracts were therefore exposed to DOC to measure their
cytoplasmic NF-xB content. Our results showed that between
days 14 and 18 of development there was a significant increase
in the cytoplasmic pool of NF-xB binding activity (Fig. 3, cf. lanes
3, 7 and 11). This binding activity was competed by excess
unlabeled xB oligonucleotide (Fig. 3, lanes 8 and 12). Hence,
during fetal thymus development, an inverse correlation between
the levels of the nuclear NF-xB and of the cytoplasmic NF-xB
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Fig. 1. NF-*B binding activity in nuclear extracts of thymus of newborn
and adult mice. (A) EMSA was done using three labeled oligonucleotides.
xB, mxB, and MHC-xB (see Table 1 for oligonucleotide sequences) A
200-fold molar excess of each unlabeled oliognucleotide was used in
the competition experiments. N, newborn; A, adult mouse. The arrows
b1 and b2 indicate the mobility of NF-xB-DNA complexes. (B) Detection
of NF-xB protein subunits by UV cross linking to [^PJxB oligonucleotide
and SDS - PAGE. DNA-binding reactions were performed with total pro-
tein extract of thymuses of newborn mice without competitors (lanes 1
and 2) of in the presence of 200-fotd molar excess of mxB cJigonudeotide
(lane 3), or 200- or 400-fold excess of xB oligonucleotide (lanes 4 and
5). xB oligonucleotide was crosslmked after DNA-binding reaction with
sequence-specific proteins using UV treatment. Then labeled proteins
were analyzed by 0.1 % SDS - 10% polyacrylamide gel electrophoresis
with protein markers. The main protein subunits of NF-xB were designated
as p50 and p65.
precursor pool was evident. A similar inverse correlation was seen
between nuclear and cytoplasmic NF-xB in samples obtained
from newborn and adult thymocytes (Fig. 3, lanes 14 and 19).
CREB binding activity during thymus ontogeny
CREB activity in fetal and adult mouse thymocytes was
determined using labeled CRE oligonucleotide (which contains
a binding site for the CREB transcription factor) (Fig. 4).
Competition experiments with different unlabeled oligonucleotides
confirmed the specificity of CREB binding activity (Fig. 4, panel
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Fig. 2. NF-xB binding activity in nuclear extracts of mouse thymus from
different stages of development Stages of development (14 days, 16
days, 18 days of embryonic development, and newborn and adult) are
shown on the top. EMSA was done using two labeled probes. [32P]xB
oligonucleotide (panels A and B) and [32P]MHC-xB oligonucleotides
(panel C) A 200-fold molar excess of unlabeled xB oligonucleotide were
used as competitor (Comp +). The arrows b1 and b2 indicate the mobility
of NF-xB - DNA complexes, the arrow f indicates the free DNA probe
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Fig. 3. Presence and specificity of the precursor of NF-xB transcription
factor in the cytoplasmic extracts of mouse thymus from different stages
of development. EMSA was done using labeled xB oTigonucleotide probe.
Cytosolic extracts were treated with 0.6% sodium deoxycholate (Doc. +)
prior to DNA binding reactions or not treated (Doc. - ) and then analyzed
on 4% norvdenaturate polyacrylamide gel. The presence of competitor,
200-fold molar excess of unlabeled xB-oligonucleotide is designated as
Comp.+ .
A). Interestingly, an excess of the AP-1 -binding otigonucleotide
(which differs from the CREB sequence by only one base) did
not inhibit CREB binding activity (Fig. 4A, lanes 5 and 6). The
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Fig. 4. CREB binding activity in nuclear extracts of thymus from different
stages of development (A). Specificity of CREB binding activity EMSA
was done using labeled CRE oligonudeotide without competitions (lanes
1 and 2) or in the presence of 200- or 400-fold excess of unlabeled CRE
oligonudeotide (lanes 3 and 4 respectively), or 200- or 400-fold excess
of unlabeled AP1 -binding oligonudeotide (lanes 5 and 6), or 200-fold
excess of xB oligonudeotide (lane 7) The arrow d indicates the mobili-
ty of the CREB - DNA complex, f indicates the free oligonudeotide pro-
be. (B). CREB activity during thymus development. The presence of
200-fold molar excess of unlabeled CRE oligonucleotide as competitor
is designated Comp +
level of CREB binding activity increased slightly during fetal
thymus development, peaking at birth and then decreased to
the adult level (Fig 4B). The main band of retardation was
designated d and longer exposure revealed some additional
minor bands of retardation (not shown).
NF-IL-2A and NF-AT1 transcription factors during thymus
ontogeny
The presence and specificity of NF-IL-2A binding activity in mouse
thymocytes was determined by EMSA with a labeled IL-2A
oligonudeotide containing the cognate sequence for the NF-IL-2A
transcription factor (Table 1). Specificity analyses using competitor
cJigonudeotides are shown in Fig. 5(A and B). Three distinct
DNA - protein complexes were observed. Bands a1 and a2 were
specific, while a3 was only partly inhibited by unlabeled IL-2A
oligonudeotide (Fig. 5A, lanes 3 and 4). Shorter exposures (6 h)
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Fig. 5. NF-IL-2A binding activity in nudear extracts of mouse thymus
from different stages of development. (A) and (B) Specificity of NF-IL-2A
binding activity. Panel (B) is the same as panel (A) but after a short-time
exposure of the autoradiogram (6 h). EMSA was done using labeled IL-2A
ofigonucleotide probe without any competitor (lanes 1, 2, 7 and 8) or
in the presence of 200- or 400-fold molar excess of different
oligonudeotides (see Table 1 for oligonucleotide sequences). The arrows
at a1, a2, and a3 indicate mobilities of different NF-IL-2A-DNA
complexes, f indicates the free olgonucteotide probe. (C) NF-IL-2A activity
during thymus development. The presence of 200-fold molar excess of
unlabeled IL-2A oligonudeotide as competitor is designated Comp. +.
oligonucleotide, MHC xB-oligonucleotide, but not MxB
oligonucleotide, partly reduced the intensity of the a3 band. In
addition, a 400-fold molar excess of xB oligonucleotide partly
inhibited labeling of band a1 (Fig. 5B).
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Similarity between human NAF-IL-2A factor and the ubiquitous
Oct1 protein has recently been established (22,38). We used an
oligonucleotide with a canonical motif as a competitor for NF-
IL-2A binding activity in EMSA experiments (Fig. 5A and B, lanes
13 and 14). We observed only partial inhibition of mouse NF-
IL-2A binding activity (bands a1 and a2, but not for band a3)
by excess unlabeled octamer oligoncleotide. This partial inhibition
was seen more clearly after shorter exposure of autoradiograms
(panel B). It is possible that bands a1 and a2 represent Oct1 and
Oct2 factors whereas band a3 represents a complex between
Oct1 and a 40 kDa Oct1 -associated protein as recently
suggested by Ullman et al. (39).
The ontogeny of NF-IL-2A binding activity in the thymus is
shown in Fig. 5(C). The intensity of bands a1 and a2 were high
initially but then decreased in the adult thymus. Band a2 seems
to be absent in the adult. In contrast, the intensity of band a3
dramatically increased during development
A complex picture emerged when the ontogeny of NF-AT1
factor binding activity was analyzed. Using a labeled
oligonucleotide with the canonical NF-AT1 binding site from the
human IL-2 gene enhancer (17) we detected two DNA - protein
retarded complexes (Fig. 6). From competition experiments with
homologous and mutated oligonucleotides, only the lower of
these two bands was specific (Fig. 6, lanes 10-13). When we
used as competitor an oiigonucleotide with the equivalent mouse
NF-AT1 (msAT) binding site, which differs from the human by
only two nucleotides (40) (see Table 1), we saw no inhibition of
binding to the human NF-AT oligonucleotide (Fig. 5A, lane 13).
Furthermore, when the mouse probe was used as the labeled
oligonucleotide, several bands were observed only one of which
was specific (msNF-AT1). The upper, non-specific band (revealed
using human NF-AT1 probe) (lanes 10-13) was also recognized
using the mouse probe (lanes 14 and 15). From these
experiments, it seemed that the human and mouse probes were
detecting specifically two different proteins which we have
designated hNF-AT1 and msNF-AT1 respectively.
The ontogeny of hNF-AT1 and msNF-AT1 appeared to be
different. Thus, significant levels of hNF-ATI activity were
observed in the fetal thymus from day 14 (Fig. 7, lanes 16-18;
Fig. 6A, lanes 1 -9 ) and this activity continued to increase with
age. However, we were unable to detect specific msNF-AT1 (the
lower band) at day 14, but by day 16 this became barely
detectable, and thereafter increased in concentration to that seen
in the adult thymus (Fig. 6, Panel B).
Fetal liver transcription factor
Having established the pattern of expression of several ubiquitous
transcription factors in the 14 day fetal thymus, we wanted to
compare the pattern seen in thymocytes with a tissue known to
be a rich source of precursor cells, i.e. the fetal liver. Results of
these experiments are shown in Fig. 7. Fetal liver cell suspensions
were enriched for hemopoietic cells by centrifugation over a
Hypaque-Ficoll gradient prior to nuclear protein purification. No
difference in NF-IL-2A or hNF-AT1 binding activity between fetal
liver and thymocytes was observed. CREB activity was
significantly increased in the thymus compared with fetal liver
extracts. However, the most dramatic difference was seen with
NF-xB, which was practically absent in fetal liver cells but present
at a high level in thymocytes.
A.
I5d 18d Adult.
< t— < I— *E - < E " < E
Adult
(- < <
- < 1 I " I °°mp-
msNFATI
; " • • * * *
f 1011 1213 14 15
1 2 3 4 5 6 7 8 9
B.
14d 16d 18d Ad
< - - < - - < - - 3 <*"*>•
S - " « i 5 -msNFATI
7 8 9 10 11 12
Fig. 6. NF-AT1 binding activity in nuclear extracts of mouse thymus from
different stages of development. EMSA was done using two labeled
probes: human NF-AT1 binding oligonucleotide (panel A, lanes 1-13)
or mouse NF-AT1 binding oligonucleotide (panel A, lanes 14 and 15,
and panel B). A 200-fold molar excess of three different oligonucleotides,
i.e. human NF-AT1 binding oligonucleotide (AT), a mutated variant of
this oligonucleotide (mAT), and mouse NF-AT1 binding odgonucleotide
(msAT), was used as competitor. The arrow hN F-AT1 indicates the position
of the NF-AT1 - DNA complex revealed by the human probe and msNF-
ATI indicates the mobility of the DNA - protein complex revealed by the
mouse probe.
Discussion
In this report, EMSA experiments have been carried out using
nuclear and cytoplasmic extracts of fetal mouse thymocytes in
order to determine qualitative and quantitative aspects of
transcription factor expression. The transcription factors studied
included NF-xB, CREB, NF-IL-2A, NF-AT1, NF-1, and AP-1, and
these were chosen because of their known critical involvement
in the regulation of genes active in mature, immunocompetent
T lymphocytes.
At day 10.5 of development, the mouse thymus is a cluster
of epithelial cells which becomes colonized by blood-borne, fetal
Irver-denved hemopoietic cells. Over the next few days, migration
of fetal liver cells continues and, by day 14, the thymus contains
1-2 x 104 hemopoietc cells and an equal number of epithelial
NFKB CREB
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Fig. 7. Transcription factor binding activity in fetal liver and thymus (14 and 15 days of gestation). EMSA was done using labeled probe for the
detection of NF-xB, CREB, NF-IL-2A, and NF-AT1 binding activities. DNA binding reactions were performed without competitor (Comp - ) or in
the presence of 200-fold molar excess of unlabeled xB oligonucleotide (lane 4), CRE oligonucleotide pane 8), IL-2A oligonucleotide (lane 2), human
NF-AT1 binding oligonucleotide (AT, lanes 14 and 17), or amutated variant of this oligonucleotide (mAT; lanes 15 and 18). The dashed lines indicate
the positions of specific DNA - protein complexes.
cells. Very little is known about the interaction(s) between epithelial
cells and hemopoietic precursors at this critical time of thymocyte
development. Most hemopoietic cells in the 14 day thymus do
not express cell surface TCRs.
However, beginning at day 14, surface expression of
gamma/delta TCR can be detected on about 3% of cells and
a truncated form of TCR-/S chain transcripts can be identified.
In addition, - 50% of cells express on their surface IL-2Ra chains
although IL-2 is not thought to play a role in the growth of fetal
thymocytes at this time (41). By day 16 of development, cells
expressing both CD4 and CD8, double positive thymocytes
appear, followed soon after by single positive CD4+ and CD8+
cells. Coincident with the appearance of double positive cells,
surface expression of the TCR-a//3 can be detected (for review,
see ref. 23). During this time, the thymus is growing exponentially,
reaching - 5 x 1 0 * cells at day 20 (birth) and - 2 x 108 cells
in the 4 week adult organ. It can be shown using organ cultures
that this differentiation process is independent of external
influences; the 14 day fetal thymus contains all the cells and
factors necessary to carry out this complex differentiation process
(26).
Expression of functional TCR-a//3 in association with the
co-receptor molecules CD4 and CD8 are known to be crucial
for cell signalling processes involved in TCR-a//3 receptor selec-
tion. Although at the phenotypic level much is known about the
ontogeny of thymocyte subpopulations and of TCR receptor gene
rearrangements, the mechanisms by which transcription factors
regulate the expression of these important events are largely
unknown. The experiments reported herein were designed to
provide information regarding the baseline expression of
transcription factors during thymus ontogeny.
Starting with NF-xB, EMSA experiments revealed that there
was a distinct pattern of expression during thymus development.
Whereas fetal liver cells from day 14 embryos contained no
detectable NF-xB binding, thymocyte nuclei at this time contained
abundant activity. As pointed out above, 14 day fetal thymocytes
are heterogeneous, as are the fetal liver cells isolated herein.
Indeed, the frequency among Ficoll-separated fetal liver cells
capable of recolonizing the fetal thymus is of the order of 1/10"
(42). In the experiments reported herein, no attempt has been
made to purify subpopulations of fetal liver cells or thymocytes.
Nevertheless, distinct differences were noted between fetal liver
and thymocytes from 14 day embryos, and we therefore consider
the increase in NF-xB expression between fetal liver and thymus
to be significant especially since other transcription factors
remained unchanged.
By the criteria of subunit composition and binding specificity,
the binding activity to the NF-xB specific oligonucleotide of mouse
thymus extracts corresponds to NF-xB which is composed of
distinct DNA binding (p50) and transactivation (p65) subunits
(35,43).
During thymus development, an inverse correlation between
nuclear and cytoplasmic concentrations of NF-xB was noted. It
is well known that NF-xB resides in the cytoplasm in an inactive
form, complexed to an inhibitor IxB, and that cellular activation
results in the dissociation of IxB from NF-xB with consequent
releases of active NF-xB (36). The dissociaton of IxB from NF-
xB can be regulated in many ways including free radicals (44)
and phosphorylation of IxB by protein kinase (45). It is also known
that the p50 subunit of NF-xB is initially synthesized as a precursor
of 105 kDa which requires processing to generate active binding
protein p50 (33,46). Thus the rate of synthesis of the p50 subunit
will also regulate the effective concentration of NF-xB.
The p50 and p65 subunits of NF-xB transcription factor have
been recently cloned and shown to belong to the Rel-related
transcription factor family (33,46-48). Using EMSA and UV
736 Transcription factors in mouse fetal thymus
crosslinking with SDS-PAGE, we have shown that nuclear
extracts of developing thymocytes contained both the
heterodimeric (p65- p50) and homodimeric (p50- p50) NF-xB
complexes. The ratio of these complexes changed during thymus
ontogeny with the highest p65 - p50 activity being found in the
day 14 fetal thymus. As the p65 - p50 NF-xB complex is a much
more effective transactivator than the p50 - p50 complex (49)
these changes in the ratio of p65 - p50 to p50 - p50 probably
reflect changes in target gene expression mediated by NF-xB
during thymus ontogeny. Presumably, the increase in NF-xB
expression by fetal liver cells entering the thymus must be
regulated by a TCR-independent mechanism and is thus different
from that seen following TCR-mediated stimulation of mature
T lymphocytes. Because NF-xB is known to be involved in the
control of IL-2R (50) and IL-2 (51) gene expression in mature
T cells, it is possible that alterations in subunit composition
combined with the high nuclear concentrations of NF-xB in the
day 14 fetal thymus may be involved in regulating IL-2R
expression by fetal mouse thymocytes. Thus, NF-xB may play
a crucial role in early fetal thymus development.
For NF-AT1, the pattern of expression during thymus
development was also complex. Using oligonucleotides
corresponding to either the human IL-2 gene enhancer or the
equivalent mouse sequence, EMSA experiments suggested that
the mouse thymus contains at least two different NF-AT1 proteins
which we have designated hNF-AT1 and msNF-AT1. These two
proteins had different patterns of expression during ontogeny.
Thus, whereas hNF-AT1 appeared to be an ubiquitous factor
expressed at a constant level throughout ontogeny (a pattern also
seen with CREB and NF-1) msNF-At1 appeared to be
developmentally regulated being first detectable on day 16 of
thymus development. The timing of msNF-ATi expression is
significant since by polymerase chain reaction (PCR) analysis,
IL-2 transcription could be initially detected only at day 16 of
thymus development (52). This result differs from a previous
report using in situ hybridization in which twowaves of IL-2
transcription at days 14 and 16 could be detected (53). Thus
our EMSA experiments suggest that msNF-AT1 may be involved
in IL-2 gene expression during thymus development, beginning
at day 16. It should be pointed out that the human NF-
AT1-binding oligonucleotides used in this study contained an Ets
binding site whereas in the mouse oiigonucleotide this sequence
was truncated and modified (Table I). The presence of this Ets
cognate sequence may account for the differences observed in
EMSA using either mouse or human oligonucleotides.
NF-IL-2A was present at a high level throughout thymus
development. Recently, it has been shown that NF-IL-2 and the
90 kDa Oct1 factor are proteins with related sequence specificity
(38). A possible interpretation of multiple bands of retardation
formed by thymic nuclear extracts with labeled IL-2A
oiigonucleotide in EMSA is that band a1 and a2 represent Oct1
and Oct2 factors whilst band a3 is a heteromeric complex
between NF-IL-2A and Oct1-associated protein (39). The
dramatic increase in the intensity of band a3 during thymus
development suggests that this type of interaction between
different transcription factor subunits increases during thymus
development.
The thymus is the primary organ where T lymphocytes are
generated. Studies to date have concentrated on the phenotypic
and functional description of events that take place in the
developing thymus. However, we remain largely ignorant as to
the molecular mechanisms governing thymocyte growth and sur-
vival, particularly during the early stages of fetal thymus
development. Ultimately, the complex series of events that guides
the differentiation of precursor T cells to functional mature T
lymphocytes must be regulated at the gene transcriptional level
The recent cloning of genes encoding transcription factor proteins
means that attempts can now be made, using transgenic mouse
technology, to manipulate the availability of such transcription
factors in developing thymocytes. By this means, the roles of
transcription factors in controlling thymocyte differentiation can
be investigated.
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